CDT Equity CDT
NASDAQ CDT
$0.34 -0.26 (-42.54%)
As of: Sep 10, 2026 · 3:59 PM EDT

CDT Equity (CDT) Net Income (2022 - 2026)

CDT Equity's (CDT) quarterly Net Income came in at -$4.6 million in Q2 2026, up 24.49% on a YoY basis from -$3.7 million in Q2 2025, and down 12.78% quarter-over-quarter from -$4.0 million in Q1 2026.

Analysis

CDT Equity (CDT) Net Income (2022 - 2026) Analysis & Trends

CDT Equity (CDT) has reported Net Income for 5 consecutive years, with -$4.6 million the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Net Income rose 24.49% year-over-year to -$4.6 million; the trailing twelve-month figure through Jun 2026 stood at -$36.9 million (down 51.68% YoY), and the FY2025 full-year result was -$40.3 million, down 76.21% from the prior year.
  • Net Income eased to -$4.6 million in Q2 2026 per CDT's latest filing, from -$4.0 million in the prior quarter.
  • Across five years, Net Income topped out at $562808.0 in Q4 2022 and bottomed at -$21.1 million in Q4 2025.
  • Historically, Net Income has averaged -$4.1 million across 5 years, with a median of -$3.9 million in 2024.
  • The sharpest annual moves came in 2023 and 2024: Net Income jumped 147.44% in 2023, then slumped 3175.61% in 2024.
  • Over 5 years, Net Income stood at $562808.0 in 2022, then tumbled by 632.86% to -$3.0 million in 2023, then sank by 124.74% to -$6.7 million in 2024, then tumbled by 212.85% to -$21.1 million in 2025, then jumped by 78.4% to -$4.6 million in 2026.
  • According to Business Quant data, Net Income over the past three periods registered -$4.6 million, -$4.0 million, and -$21.1 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Income (Qtr)
1 Johnson & Johnson 641.14 Bn 620.38 Bn 17.26 Bn 5.53 Bn
2 AbbVie 451.04 Bn 444.47 Bn 12.70 Bn 3.62 Bn
3 Merck 357.43 Bn 350.29 Bn 12.21 Bn -1.34 Bn
4 Novartis Ag 266.73 Bn 259.04 Bn 11.24 Bn 5.28 Bn
5 Pfizer 157.52 Bn 145.82 Bn 10.94 Bn -238.00 Mn
6 Sanofi 52.14 Bn 44.76 Bn 10.79 Bn 2.16 Bn
7 Revolution Medicines 42.88 Bn 42.88 Bn - -644.37 Mn
8 Incyte 24.70 Bn 20.16 Bn 1.57 Bn 585.61 Mn
9 United Therapeutics 21.47 Bn 18.80 Bn 683.80 Mn 333.00 Mn
10 CDT Equity 187,135.95 187,135.95 - -4.56 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -4.56 Mn
Mar 31, 2026 -4.04 Mn
Dec 31, 2025 -21.09 Mn
Sep 30, 2025 -7.27 Mn
Jun 30, 2025 -6.03 Mn
Mar 31, 2025 -4.76 Mn
Dec 31, 2024 -6.74 Mn
Sep 30, 2024 -6.83 Mn
Jun 30, 2024 -5.60 Mn
Mar 31, 2024 -3.70 Mn
Dec 31, 2023 -3.00 Mn
Sep 30, 2023 -726,000.00
Jun 30, 2023 -343,711.00
Mar 31, 2023 120,269.00
Dec 31, 2022 562,808.00
Sep 30, 2022 206,906.00
Jun 30, 2022 -117,539.00
Mar 31, 2022 -253,536.00